BMS 204352

Stock Code: 3574739
Manufacturer Part No: SML1313-25MG
Order Now for 7 day delivery
£834.32 (exc VAT) per 25MG
Quantity: - +

Application


BMS 204352 has been used in drug administration.


Biochem/physiol Actions


BMS 204352 (MaxiPost [(3S)-(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one)] is used to treat ischemic stroke. It also acts as an activator of KNCQ4 (KQT-like subfamily, member 4) and KCNQ5 (KQT-like subfamily, member 5) with equal potency.


BMS 204352 is a potassium channel modulator. Originally developed as a potent opener of large-conductance, calcium-activated (Maxi-K, KCa1.1, BK) potassium channels, BMS 204352 also acts as a positive modulator at Kv7 (KCNQ) channels.


Packaging


5, 25 mg in glass bottle

Colourwhite to beige
Quality Level100
InChI keyULYONBAOIMCNEH-HNNXBMFYSA-N
InChI1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1
ManufacturerSIGMA-ALDRICH
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.